Clinical Trials

Infantile Hemangioma

Posted on 1/2/2019
This study is being conducted in infants with one or more hemangiomas (hemangioma is a birthmark that most commonly appears as a rubbery, bright red nodule of extra blood vessels in the skin.)  The purpose of the study is to assess the effectiveness of 2 different strengths of the study medication which is applied directly on the hemangioma.

Your child may qualify if:
 
  • Your child is 0-84 days of age
  • You are the parent or have documentation of legal guardianship
  • Your child's hemangioma has not been previously treated with any other type of drug or laser therapy

Your child's participation in the study will last up to 270 days with 7 visits to the clinic and 2 phone contacts.  You will be compensated for your time and travel up to $350 for your child's participation in the study. 
What Our Research Patients are Saying
Everyone at DCOL Research is friendly and helpful. They all have a great sense of humor, which really helps you relax.  I have participated in several studies with them and the research coordinator I see is awesome. She makes you feel that your health is her top priority.  The research doctor is really good too and if you start having problems during the study he will take care of you. This research clinic is like a family, and once you participate in a study, you are just part of the family.     R. O.

Contact Form


  
DCOL of Longview